EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Research Progress in Modified Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis

Na Yang, Yueyang Liu

Journal of Clinical Medicine Research · 15.07.2026 · 7 (2) · 321

DOI: 10.32629/jcmr.v7i2.5331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine Research, online erschienen am 15.07.2026. Verfasst von Na Yang und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis is a common chronic inflammatory bowel disease with insidious onset and recurrent episodes. Although Western medicine can maintain clinical remission, it still fails to meet patients' therapeutic expectations. Gegen Qinlian Decoction improves intestinal mucosal barrier function and attenuates systemic and tissue inflammatory responses with remarkable clinical efficacy. This article reviews the research progress of modified Gegen Qinlian Decoction in the treatment of ulcerative colitis, aiming to provide a theoretical basis for the clinical diagnosis and treatment of ulcerative colitis.

Zitieren

APA

Yang, N., & Liu, Y. (2026). Research Progress in Modified Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis. Journal of Clinical Medicine Research, 7(2), 321. https://doi.org/10.32629/jcmr.v7i2.5331

Vancouver

Yang N, Liu Y. Research Progress in Modified Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis. Journal of Clinical Medicine Research. 2026;7(2):321. doi:10.32629/jcmr.v7i2.5331

BibTeX
@article{Yang2026,
  author = {Yang, Na and Liu, Yueyang},
  title = {Research Progress in Modified Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis},
  journal = {Journal of Clinical Medicine Research},
  year = {2026},
  volume = {7},
  number = {2},
  pages = {321},
  doi = {10.32629/jcmr.v7i2.5331}
}
Kostenlos starten →